CD8A and hepatocellular carcinoma: Then, we used an HCC mouse model established by hepatic portal vein injection of murine liver cancer cells expressing shmHKDC1s or Non-targeted control (NTC) and quantified exhaustion and activity of tumor-infiltrating CD8+ T cells.